XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
3 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Fair Value Of Stock Options Granted, Assumptions
The Company determined the fair value of stock options granted during the three months ended December 31, 2020 based upon the assumptions as provided below. No stock options were granted during the three months ended December 31, 2021.
Stock price
$10.00
Exercise price
$10.01
Dividend yield
0 %
Expected volatility
60 %
Risk-Free interest rate
0.63 %
Expected life (in years)
6.08
Summary of Stock Option Activities
Following is a summary of stock option activities for the three months ended December 31, 2021:
OptionsWeighted
Average
Exercise Price
Weighted
Average
Grant Date
Fair Value
Weighted
Average
Remaining
Life
(years)
Intrinsic
Value
Outstanding – October 1, 2021
8,978,185 $0.19 $0.20 5.7$91,699 
Granted— — — 
Exercised(893,509)0.18 0.16 
Forfeited— — — 
Outstanding – December 31, 2021
8,084,676 $0.19 $0.21 5.6$69,875 
Exercisable as of December 31, 2021
8,084,676 $0.19 $0.21 5.6$69,875 
Summary of Restricted Stock Activity

Restricted Stock Awards
Weighted Average Grant Date
Fair Value
Restricted Stock Units
Weighted Average Grant Date
Fair Value
Non-vested – October 1, 2021684,937 $10.00 1,452,195 $7.61 
Granted
— — 970,545 8.96 
Vested
(684,937)10.00 (32,848)7.53 
Forfeited
— — (16,369)8.58 
Non-vested – December 31, 2021
— $— 2,373,523 $8.22 
Summary of Stock-based Compensation Expense
Stock-based compensation expense for stock options and restricted stock in the unaudited interim condensed consolidated statements of operations is summarized as follows:
Three Months Ended December 31,
20212020
Software development
$297 $18 
General and administrative
2,565 1,257 
Selling and marketing
69 —
Total stock-based compensation expense
$2,931 $1,275